Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006–18: prospective observational time-series and case-control studies-Reference-Cited by-同舟云学术

Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006–18: prospective observational time-series and case-control studies

Published:2021-07 Issue:7 Volume:9 Page:e989-e998
ISSN:2214-109X
Container-title:The Lancet Global Health
language:en
Short-container-title:The Lancet Global Health

Author:

Bar-Zeev Naor,Swarthout Todd D,Everett Dean B,Alaerts Maaike,Msefula Jacquline,Brown Comfort,Bilima Sithembile,Mallewa Jane,King Carina,von Gottberg Anne,Verani Jennifer R,Whitney Cynthia G,Mwansambo Charles,Gordon Stephen B,Cunliffe Nigel A,French Neil,Heyderman Robert S

Funder

Bill & Melinda Gates Foundation

Publisher

Elsevier BV

Subject

General Medicine

Reference39 articles.

1. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15;Wahl;Lancet Glob Health,2018

2. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates;O'Brien;Lancet,2009

3. Effect on nasopharyngeal pneumococcal carriage of replacing PCV7 with PCV13 in the Expanded Programme of Immunization in The Gambia;Roca;Vaccine,2015

4. High residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi;Swarthout;Nat Commun,2020

5. Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study;Mackenzie;Lancet Infect Dis,2016

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Why pneumococcal surveillance must continue;The Lancet Global Health;2024-09

2. Inequitable Distribution of Global Economic Benefits from Pneumococcal Conjugate Vaccination;Vaccines;2024-07-12

3. Serotype distribution of invasive pneumococcal disease from countries of the WHO Africa, Americas, Eastern Mediterranean, South-East Asia, and Western Pacific regions: a systematic literature review from 2010 to 2021;Frontiers in Public Health;2024-07-10

4. Expansion of pneumococcal serotype 23F and 14 lineages with genotypic changes in capsule polysaccharide locus and virulence gene profiles post introduction of pneumococcal conjugate vaccine in Blantyre, Malawi;Microbial Genomics;2024-06-19

5. Estimating pneumococcal carriage dynamics in adults living with HIV in a mature infant pneumococcal conjugate vaccine program in Malawi, a modelling study;2024-05-01